In response: Letter on update to the Vitamin C, Thiamine and Steroids in Sepsis (VICTAS) protocol

ClinicalTrials.gov: NCT03509350. Registered on 26 April 2018.

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Current controlled trials in cardiovascular medicine 2020-04, Vol.21 (1), p.351-351, Article 351
Hauptverfasser:	Lindsell, Christopher J, McGlothlin, Anna, Nwosu, Samuel, Rice, Todd W, Hall, Alex, Bernard, Gordon R, Busse, Laurence W, Ely, E Wesley, Fowler, Alpha A, Gaieski, David F, Hinson, Jeremiah S, Hooper, Michael H, Jackson, James C, Kelen, Gabor D, Levine, Mark, Martin, Greg S, Rothman, Richard E, Sevransky, Jonathan E, Viele, Kert, Wright, David W, Hager, David N
Format:	Artikel
Sprache:	eng
Schlagworte:	Anti-Inflammatory Agents - therapeutic use Ascorbic Acid - therapeutic use Critical care Drug dosages Drug Therapy, Combination Funding Humans Hydrocortisone - therapeutic use Letter Pyrimidines R&D Research & development Sepsis Sepsis - drug therapy Steroids Thiamine - therapeutic use Time-to-Treatment Treatment Outcome Vitamin B Vitamin B Complex - therapeutic use Vitamin C
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	ClinicalTrials.gov: NCT03509350. Registered on 26 April 2018.
ISSN:	1745-6215 1745-6215
DOI:	10.1186/s13063-020-04290-6